NCT01815593

Brief Summary

The purpose of this study is to investigate the efficacy of Enhanced External Counterpulsation (EECP) in patients with erectile dysfunction

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
120

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Apr 2013

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 16, 2013

Completed
5 days until next milestone

First Posted

Study publicly available on registry

March 21, 2013

Completed
11 days until next milestone

Study Start

First participant enrolled

April 1, 2013

Completed
4.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2018

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2018

Completed
Last Updated

April 4, 2017

Status Verified

April 1, 2017

Enrollment Period

4.9 years

First QC Date

March 16, 2013

Last Update Submit

April 2, 2017

Conditions

Keywords

Erectile DysfunctionVascular EndotheliumCounterpulsation, External

Outcome Measures

Primary Outcomes (1)

  • Erectile function evaluated by International Index of Erectile Function-5 questionnaire

    7 weeks

Secondary Outcomes (1)

  • Endothelial function

    7 weeks

Study Arms (2)

Enhanced External Counterpulsation

EXPERIMENTAL

Men with erectile dysfunction receive Enhanced External Counterpulsation treatment

Device: Enhanced external counterpulsation

Control

NO INTERVENTION

Men with erectile dysfunction without Enhanced External Counterpulsation treatment

Interventions

Enhanced external counterpulsation therapy is done by sequential inflation of 3 sets of cuffs wrapped around the lower extremities during diastole and deflation of the cuffs during systole. The systolic deflation/ Diastolic inflation sequence of EECP leads to systolic unloading and diastolic augmentation, resulting in increased blood flow in a pulsatile manner. The patients receive 35-36 hours EECP intervention, 1 -hour session every day over a 7-week period.

Also known as: EECP
Enhanced External Counterpulsation

Eligibility Criteria

Age18 Years - 80 Years
Sexmale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • men over 18 years old;
  • provide signed informed consent;
  • existence of erectile dysfunction
  • agree not to use any other erectile dysfunction treatment at least one month;

You may not qualify if:

  • history of long drug abuse;
  • pelvic, spine, brain trauma or surgery;
  • endocrine, liver, lung, kidney disease, malignancies, hematological disorders;
  • abnormal urogenital status, such as small testicle (\<2cm), penile plaques;

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

First Affiliated Hospital, Sun Yat-sen University

Guangzhou, Guangdong, 510080, China

RECRUITING

Related Publications (1)

  • El-Sakka A, Morsy A, Fagih B. Enhanced external counterpulsation in patients with coronary artery disease-associated erectile dysfunction. Part I: effects of risk factors. J Sex Med. 2007 May;4(3):771-779. doi: 10.1111/j.1743-6109.2007.00458.x. Epub 2007 Apr 13.

    PMID: 17433083BACKGROUND

MeSH Terms

Conditions

Erectile Dysfunction

Condition Hierarchy (Ancestors)

Genital Diseases, MaleGenital DiseasesUrogenital DiseasesSexual Dysfunction, PhysiologicalMale Urogenital DiseasesSexual Dysfunctions, PsychologicalMental Disorders

Study Officials

  • Yan Zhang, M. D.

    First Affiliated Hospital, Sun Yat-Sen University

    STUDY DIRECTOR

Central Study Contacts

Yadong Zhang, M. D.

CONTACT

Zi Wan, M. D.

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Patients with erectile dysfunction are assigned to two groups in parallel for the duration of the study
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

March 16, 2013

First Posted

March 21, 2013

Study Start

April 1, 2013

Primary Completion

March 1, 2018

Study Completion

April 1, 2018

Last Updated

April 4, 2017

Record last verified: 2017-04

Data Sharing

IPD Sharing
Will not share

Locations